1. Academic Validation
  2. Synthetic conjugates of genistein affecting proliferation and mitosis of cancer cells

Synthetic conjugates of genistein affecting proliferation and mitosis of cancer cells

  • Bioorg Med Chem. 2011 Jan 1;19(1):295-305. doi: 10.1016/j.bmc.2010.11.024.
Aleksandra Rusin 1 Jadwiga Zawisza-Puchałka Katarzyna Kujawa Agnieszka Gogler-Pigłowska Joanna Wietrzyk Marta Switalska Magdalena Głowala-Kosińska Aleksandra Gruca Wiesław Szeja Zdzisław Krawczyk Grzegorz Grynkiewicz
Affiliations

Affiliation

  • 1 Department of Tumor Biology, Maria Sklodowska-Curie Memorial Cancer Center and the Institute of Oncology, Wybrzeze AK 15, 44-100 Gliwice, Poland. arusin@io.gliwice.pl
Abstract

This paper describes the synthesis and antiproliferative activity of conjugates of genistein (1) and unsaturated pyranosides. Constructs linking genistein with a sugar moiety through an alkyl chain were obtained in a two-step synthesis: in a first step genistein was converted into an intermediate bearing an ω-hydroxyalkyl substituent, containing two, three or five carbon atoms, at position 7, while the second step involved Ferrier glycosylation reaction, employing glycals. Antiproliferative activity of several genistein derivatives was tested in Cancer cell lines in vitro. The most potent derivative, Ram-3 inhibited the cell cycle, interacted with mitotic spindles and caused apoptotic cell death. Neither genistein nor the sugar alone were able to influence the mitotic spindle organization. Our results indicate, that conjugation of genistein with certain sugars may render the interaction of derivatives with new molecular targets.

Figures